Peptides derived from ICAM-1 and LFA-1 modulate T cell adhesion and immune function in a mixed lymphocyte culture

Transplantation

Volumn 68, Issue 5, 1999, Pages 685-692

  Tibbetts, Scott A ^a   Chirathaworn, Chintana ^a,b   Nakashima, Mikio ^a   Jois, D S Seetharama ^a   Siahaan, Teruna J ^a   Chan, Marcia A ^a   Benedict, Stephen H ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PEPTIDE HORMONE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; COS CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0033568283     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909150-00015     Document Type: Article

References (47)

1. Larson R, Springer T. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 118.
2. van de Stolpe A, van der Saag P. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13.
3. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with anti-ICAM-1 and anti-LFA-1. Science 1992; 255: 1125.
4. Stepkowski S, Tu Y, Condon T, Bennett C. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol 1994; 153: 5336.
5. Cosimi A, Conti D, Delmonico F, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144: 4604.
6. Nakakura E, McCabe S, Zheng B, et al. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation 1993; 55: 412.
7. Talento A, Nguyen M, Blake T, et al. A single administration of LFA-1 antibody confers prolonged allograft survival. Transplantation 1993; 55: 418.
8. Cavazzana-Calvo M, Sarnacki S, Haddad E, et al. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Transplantation 1995; 59: 1576.
9. Hasegawa Y, Yokono K, Taki T, et al. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int Immunol 1994; 6: 831.
10. Davis L, Kavanaugh A, Nichols L, Lipsky P. Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol 1995; 154: 3525.
11. Kavanaugh A, David L, Nichols L, et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum 1994; 37: 992.
12. Staunton D, Dustin M, Erickson H, Springer T. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61: 243.
13. Edwards C, Champe M, Gonzalez T, et al. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 1995; 270: 12635.
14. Stanley P, Bates P, Harvey J, Bennett R , Hogg N. Integrin LFA-1 α subunit contains an ICAM-1 binding site in domains V and VI. EMBO J 1994; 13: 1790.
15. Randi A, Hogg N. I domain of β32 integrin lymphocyte functionassociated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1. J Biol Chem 1994; 269: 12395.
16. Bajt M, Goodman T, McGuire S. β2 (CD18) mutations abolish ligand recognition by I domain integrins LFA-1 (αLβ2, CD11a/ CD18) and MAC-1 (αMβ2, CD11b/CD18). J Biol Chem 1995; 270: 94.
17. Fecondo J, Kent S, Boyd A. Inhibition of intercellular adhesion molecule 1-dependent biological activities by a synthetic peptide analog. Proc Natl Acad Sci USA 1991; 88: 2879.
18. Ross L, Hassman F, Molony L. Inhibition of Molt-4-endothelial adherence by synthetic peptides from the sequence of ICAM-1. J Biol Chem 1992; 267: 8537.
19. Fecondo J, Pavuk N, Silburn K, et al. Synthetic peptide analogs of intercellular adhesion molecule-1 (ICAM-1) inhibit HIV replication in MT-2 cells. AIDS Res Hum Retroviruses 1993; 9: 733.
20. Seth R, Salcedo R, Patarroyo M, Makgoba M. ICAM-2 peptides mediate lymphocyte adhesion by binding to CD11a/CD18 and CD49d/CD29 integrins. FEBS Lett 1991; 282: 193.
21. Li R, Nortamo P, Valmu L, et al. A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J Biol Chem 1993; 268: 17513.
22. Nowlin D, Gorcsan F, Moscinski M, Chiang S, Lobl T, and Cardarelli P. A novel cyclic pentapeptide inhibits αβ1 and α5β1 integrin-mediated adhesion. J Biol Chem 1993; 268: 20352.
23. Barker P, Bullens S, Bunting S, et al. Cyclic RGD peptide analogues as antiplatelet antithrombotics. J Med Chem 1992; 35: 2040.
24. Linsley P, Brady W, Urnes M, Grosmaire L, Damle N, Ledbetter J. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
25. Chirathaworn C, Tibbetts S, Chan M, Benedict S. Cross-linking of ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J Immunol 1995; 155: 5479.
26. de Fougerolles A, Stacker S, Schwarting R, Springer T. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174: 253.
27. Kansas G, Tedder T. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J Immunol 1991; 147: 4094.
28. Kingston R, Chen C, Okayama H. Transfection of DNA into eukaryotic cells. In: Ausubel F, Brent R, Kingston R, eds. Current protocols in molecular biology. New York: John Wiley & Sons, 1990; 1: 9.1.1-9.1.9.
29. Kruisbeek A, Shevach E. Proliferative assays for T cell function. In: Current protocols in immunology. Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W, eds. Greene Publishing Associates, and New York: John Wiley & Sons, 1991; 1: 3.12.1-3.12.14.
30. van Seventer G, Bonvini E, Yamada H, et al. Costimulation through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 1992; 149: 3872.
31. Kanner S, Grosmaire L, Ledbetter J, Damle N. Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1 activation. Proc Natl Acad Sci USA 1993; 90: 7099.
32. Arroyo A, Campanero M, Sanchez-Mateos P, et al. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J Cell Biol 1994; 126: 1277.
33. Wang S, Kanner S, Ledbetter J, Gupta S, Kumar G, Nel A. Evidence for LFA-1/ICAM-1 dependent stimulation of protein tyrosine phosphorylation in human B lymphoid cell lines during homotypic adhesion. J Leukoc Biol 1995; 57: 343.
34. Yamada K, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995; 7: 681.
35. Petruzzelli L, Takami M, Herrera R. Adhesion through the interaction of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 induces tyrosine phosphorylation of p130cas and its association with c-CrkII. J Biol Chem 1996; 271: 7796.
36. Rothlein R, Dustin M, Marlin S, Springer T. A human intercellular adhesion molecule-1 (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270.
37. Durieu-Trautmann O, Chaverot N, Cazaubon S, Strosberg A, Couraud P. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeletal-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem 1994; 269: 12536.
38. Poudrier J, Owens T. CD54/intercellular adhesion molecule 1 and major histocompatability complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med 1994; 179: 1417.
39. Rothlein R, Kishimoto T, Mainolfi E. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J Immunol 1994; 152: 2488.
40. van Horssen M, Loman S, Rijkers G, Boom S, Bloem A. Coligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling. Eur J Immunol 1995; 25: 154.
41. Stanley P, Hogg N. The I domain of integrin LFA-1 interacts with ICAM-1 domain 1 at residue Glu-34 but not Gln-73. J Biol Chem 1998; 273(6): 3358.
42. Larson R, Corbi A, Berman L, Springer T. Primary structure of the leukocyte associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily. J Cell Biol 1989; 108: 703.
43. Landis R, McDowall A, Holness C, Littler A, Simmons D, Hogg N. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J Cell Biol 1994; 126: 529.
44. Huang C, Springer T. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J Biol Chem 1995; 270: 19008.
45. van Kooyk Y, Binnerts M, Edwards C, et al. Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function. J Exp Med 1996; 183: 1247.
46. D'Souza S, Ginsberg M, Burke T, Lam S-T, Plow E. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 1988; 242: 91.
47. D'Souza S, Ginsberg M, Matsueda G, Plow E. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 1991; 350: 66.